Clinical Trial Update: Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

View source ↗

Summary

This clinical trial update outlines efforts to define standardized PET imaging response criteria for people with neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroendocrine Tumors | Status: ACTIVE_NOT_RECRUITING